The molecule, called CXCL5, is part of a family of proteins named chemokines that recruit inflammatory immune cells to injured tissue, triggering pain and tenderness.
Research carried out on rats showed a neutralizing antibody targeting CXCL5 significantly reduced sensitivity to sunburn pain, according to the study, to be published in Science Translational Medicine.
Read the Science Daily report on sunburn pain treatment.
Related Articles on Pain Management:
Psychiatrist Tackles Problem of Defining Pain Using Greek Philosophy
Stanford Hospital & Clinics to Open Headache Clinic
FDA Approves Lazanda Nasal Spray for Cancer Pain
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
